Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
107.50
-0.50 (-0.46%)
Apr 20, 2026, 1:24 PM CST

TPE:6919 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
168,088240,25094,36523,5407,528-
Market Cap Growth
24.17%154.60%300.87%212.69%--
Enterprise Value
163,199233,73884,68522,6946,297-
Last Close Price
108.00155.0061.5019.136.11-
PS Ratio
4418.826316.212123.71604.64587.23-
PB Ratio
17.9525.539.736.296.47-
P/TBV Ratio
17.9525.539.736.296.47-
EV/Sales Ratio
-6145.021905.86582.91491.18-
Debt / Equity Ratio
000.000.010.030.06
Net Debt / Equity Ratio
-0.52-0.52-1.00-0.99-0.93-0.87
Net Debt / EBITDA Ratio
6.967.0913.887.483.582.60
Net Debt / FCF Ratio
14.0510.9818.148.534.214.44
Asset Turnover
0.000.000.010.020.010.03
Inventory Turnover
2.194.017.045.992.252.41
Quick Ratio
43.95106.97183.4250.4823.0415.00
Current Ratio
45.21109.71184.0250.8123.4115.26
Return on Equity (ROE)
-3.00%-3.68%-8.76%-19.92%-31.64%-64.89%
Return on Assets (ROA)
-4.73%-4.59%-6.59%-12.68%-20.53%-30.68%
Return on Capital Employed (ROCE)
-7.70%-7.50%-7.40%-13.70%-27.00%-34.30%
Earnings Yield
-0.17%-0.15%-0.62%-2.08%-3.80%-
FCF Yield
-0.21%-0.18%-0.56%-1.84%-3.41%-
Buyback Yield / Dilution
-5.54%-7.94%-15.40%-5.77%-27.35%-23.49%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.